De Kouchkovsky I., Abdul-Hay M. 2016. Acute myeloid leukemia: A comprehensive review and 2016 update. Blood Cancer J. 6, e441.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandez H.F., Sun Z., Yao X., Litzow M.R., Luger S.M., Paietta E.M., Racevskis J., Dewald G.W., Ketterling R.P., Bennett J.M., Rowe J.M., Lazarus H.M., Tallman M.S. 2009. Anthracycline dose intensification in acute myeloid leukemia. N. Engl. J. Med. 361, 1249‒1259.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coombs C.C., Tavakkoli M., Tallman M.S. 2015. Acute promyelocytic leukemia: Where did we start, where are we now, and the future. Blood Cancer J. 5, e304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerra V.A., DiNardo C., Konopleva M. 2019. Venetoclax-based therapies for acute myeloid leukemia. Best Pract. Res. Clin. Haematol. 32, 145‒153.

Article  PubMed  PubMed Central  Google Scholar 

Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., Bruncko M., Deckwerth T.L., Dinges J., Hajduk P.J., Joseph M.K., Kitada S., Korsmeyer S.J., Kunzer A.R., Letai A., Li C., Mitten M.J., Nettesheim D.G., Ng S., Nimmer P.M., O’Connor J.M., Oleksijew A., Petros A.M., Reed J.C., Shen W., Tahir S.K., Thompson C.B., Tomaselli K.J., Wang B., Wendt M.D., Zhang H., Fesik S.W., Rosenberg S.H. 2005. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 435, 677‒681.

Article  ADS  CAS  PubMed  Google Scholar 

Matthews J.P., Bishop J.F., Young G.A., Juneja S.K., Lowenthal R.M., Garson O.M., Cobcroft R.G., Dodds A.J., Enno A., Gillett E.A., Hermann R.P., Joshua D.E., Ma D.D., Szer J., Taylor K.M., Wolf M., Bradstock K.F., Australian Leukemia Study G. 2001. Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia. Br. J. Haematol. 113, 727‒736.

Article  CAS  PubMed  Google Scholar 

Menendez-Pelaez A., Reiter R.J. 1993. Distribution of melatonin in mammalian tissues: The relative importance of nuclear versus cytosolic localization. J. Pineal Res. 15, 59‒69.

Article  CAS  PubMed  Google Scholar 

Pourhanifeh M.H., Mahdavinia M., Reiter R.J., Asemi Z. 2019. Potential use of melatonin in skin cancer treatment: A review of current biological evidence. J. Cell. Physiol. 234, 12142‒12148.

Article  CAS  PubMed  Google Scholar 

Pourhanifeh M.H., Mehrzadi S., Kamali M., Hosseinzadeh A. 2020. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways. Eur. J. Pharmacol. 886, 173471.

Article  CAS  PubMed  Google Scholar 

Wang J., Xiao X., Zhang Y., Shi D., Chen W., Fu L., Liu L., Xie F., Kang T., Huang W., Deng W. 2012. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J. Pineal Res. 53, 77‒90.

Article  CAS  PubMed  Google Scholar 

Anderson G. 2020. The effects of melatonin on signaling pathways and molecules involved in glioma: Melatonin and glioblastoma: Pathophysiology and treatment. Fundam. Clin. Pharmacol. 34, 189‒191.

Article  CAS  PubMed  Google Scholar 

Buyukavci M., Ozdemir O., Buck S., Stout M., Ravindranath Y., Savasan S. 2006. Melatonin cytotoxicity in human leukemia cells: Relation with its pro-oxidant effect. Fundam. Clin. Pharmacol. 20, 73‒79.

Article  CAS  PubMed  Google Scholar 

Bejarano I., Redondo P.C., Espino J., Rosado J.A., Paredes S.D., Barriga C., Reiter R.J., Pariente J.A., Rodriguez A.B. 2009. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J. Pineal Res. 46, 392‒400.

Article  CAS  PubMed  Google Scholar 

Shafabakhsh R., Mirzaei H., Asemi Z. 2020. Melatonin: A promising agent targeting leukemia. J. Cell Biochem. 121, 2730‒2738.

Article  CAS  PubMed  Google Scholar 

Plaimee P., Weerapreeyakul N., Barusrux S., Johns N.P. 2015. Melatonin potentiates cisplatin-induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells. Cell Proliferation. 48, 67‒77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi C., Zhang Y., Yu Z., Xiao Y., Wang J., Qiu H., Yu W., Tang R., Yuan Y., Guo W., Deng W. 2014. Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-kappaB/p300 signaling pathways. PLoS One. 9, e99943.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Shen Y.Q., Guerra-Librero A., Fernandez-Gil B.I., Florido J., Garcia-Lopez S., Martinez-Ruiz L., Mendivil-Perez M., Soto-Mercado V., Acuna-Castroviejo D., Ortega-Arellano H., Carriel V., Diaz-Casado M.E., Reiter R.J., Rusanova I., Nieto A., Lopez L.C., Escames G. 2018. Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. J. Pineal Res. 64 (3), e12461. https://doi.org/10.1111/jpi.12461

Gao Y., Xiao X., Zhang C., Yu W., Guo W., Zhang Z., Li Z., Feng X., Hao J., Zhang K., Xiao B., Chen M., Huang W., Xiong S., Wu X., Deng W. 2017. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways. J. Pineal Res. 62 (2), e12380. https://doi.org/10.1111/jpi.12380

Baburina Y., Lomovsky A., Krestinina O. 2021. Melatonin as a potential multitherapeutic agent. J. Pers. Med. 11 (4), 274.

Article  PubMed  PubMed Central  Google Scholar 

Krestinina O., Fadeev R., Lomovsky A., Baburina Y., Kobyakova M., Akatov V. 2018. Melatonin can strengthen the effect of retinoic acid in HL-60 cells. Int. J. Mol. Sci. 19, 2873.

Article  PubMed  PubMed Central  Google Scholar 

Lomovsky A., Baburina Y., Odinokova I., Kobyakova M., Evstratova Y., Sotnikova L., Krestinin R., Krestinina O. 2020. Melatonin can modulate the effect of navitoclax (ABT-737) in HL-60 cells. Antioxidants (Basel). 9 (11), 1143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lomovsky A.I., Baburina Y.L., Fadeev R.S., Lomovskaya Y.V., Kobyakova M.I., Krestinin R.R., Sotnikova L.D., Krestinina O.V. 2023. Melatonin can enhance the effect of drugs used in the treatment of leukemia. Biochemistry (Moscow). 88, 73‒85.

CAS  PubMed  Google Scholar 

Lomovsky A.I., Baburina Y.L., Kobyakova M.I., Fadeev R.S., Akatov V.S., Krestinina O.V. 2020. Melatonin enhances the chemotherapeutic effect of cytarabin in HL-60 cells Biochemistry (Moscow), Suppl. Ser. A. 14 (2), 140‒145.

Google Scholar 

Zeeshan H.M., Lee G.H., Kim H.R., Chae H.J. 2016. Endoplasmic reticulum stress and associated ROS. Int. J. Mol. Sci. 17, 327.

Article  PubMed  PubMed Central  Google Scholar 

Huber T.B., Walz G., Kuehn E.W. 2011. mTOR and rapamycin in the kidney: Signaling and therapeutic implications beyond immunosuppression. Kidney Int. 79, 502‒511.

Article  CAS  PubMed  Google Scholar 

Cybulsky A.V. 2013. The intersecting roles of endoplasmic reticulum stress, ubiquitin−proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease. Kidney Int. 84, 25‒33.

Article  CAS  PubMed  Google Scholar 

Yuzefovych L.V., LeDoux S.P., Wilson G.L., Rachek L.I. 2013. Mitochondrial DNA damage via augmented oxidative stress regulates endoplasmic reticulum stress and autophagy: Crosstalk, links and signaling. PLoS One. 8, e83349.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer. 26, 171‒176.

Article  CAS  PubMed  Google Scholar 

Schwende H., Fitzke E., Ambs P., Dieter P. 1996. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 59, 555‒561.

Article  CAS  PubMed  Google Scholar 

Daigneault M., Preston J.A., Marriott H.M., Whyte M.K., Dockrell D.H. 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 5, e8668.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Mediavilla M.D., Cos S., Sanchez-Barcelo E.J. 1999. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci. 65, 415‒420.

Article  CAS  PubMed  Google Scholar 

Fornas O., Mato M.E., Webb S.M. 2000. Antiproliferative effect and cell cycle modulation by melatonin on GH(3) cells. Horm. Res. 53, 251‒255.

CAS  PubMed  Google Scholar 

Bejarano I., Espino J., Marchena A.M., Barriga C., Paredes S.D., Rodriguez A.B., Pariente J.A. 2011. Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells. Mol. Cell. Biochem. 353, 167‒176.

Article  CAS  PubMed  Google Scholar 

Czabotar P.E., Lessene G., Strasser A., Adams J.M. 2014. Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat. Rev. Mol. Cell. Biol. 15, 49‒63.

Article  CAS  PubMed  Google Scholar 

Bonora M., Pinton P. 2014. The mitochondrial permeability transition pore and cancer: Molecular mechanisms involved in cell death. Front. Oncol. 4, 302.

Article  PubMed  PubMed Central  Google Scholar 

Boga J.A., Caballero B., Potes Y., Perez-Martinez Z., Reiter R.J., Vega-Naredo I., Coto-Montes A. 2019. Therapeutic potential of melatonin related to its role as an autophagy regulator: A review. J. Pineal Res. 66, e12534.